Patrice X. Petit | Signal Transduction | Best Researcher Award

Published on by NESIN Awards

Dr. Patrice X. Petit | signal transduction | Best Researcher Award

 Research director | Centre National de la Recherche Scientifique | France

Dr. Patrice X. Petit, Doctor ès Sciences and PhD in Biology, is a Research Director at the French National Centre for Scientific Research (CNRS), where he has served since 1979 and established an internationally recognized career in cell biology. Trained at the Université Pierre et Marie Curie and the Université Denis Diderot (Paris), his work has focused on the molecular mechanisms governing cell death, mitochondrial dynamics, oxidative stress, and their implications in cancer biology, immunology, and toxicology. Over more than four decades, he has developed a broad international scientific presence through extensive teaching and research collaborations across Europe, North America, and Asia, including academic engagements with institutions such as the Chinese Academy of Sciences, Caltech, UT Southwestern, the Beatson Cancer Research Center in Glasgow, the University of Madrid, and multiple leading universities throughout Scandinavia, Germany, and France. His scientific leadership is further reflected in his service as an elected member (2016–2020) of the Scientific Council of the CNRS Institute of Biological Sciences (INSB). Dr. Petit has authored 134 scientific publications, accumulating approximately 12,500 citations and an h-index of 44, demonstrating sustained research influence across several biomedical domains, including contributions to plant biology. He is an active peer reviewer for major journals such as Cancer Research, Journal of Cell Biology, PNAS, Oncogene, and Cell Death and Differentiation, and he has served as a grant reviewer for major funding bodies, including the Austrian Academy of Sciences, the French National Research Agency (ANR), EMBO, the Swiss National Science Foundation, and the Fondation pour la Recherche Médicale. His interdisciplinary background—ranging from a formal qualification in history (Université Paris Diderot, 1979) to a DIU in rare diseases (Université de Strasbourg, 2017)—underscores both scientific depth and broader intellectual engagement. Through his sustained research output, international collaborations, and service to the scientific community, Patrice X. Petit has contributed significantly to advancing fundamental and translational knowledge in cell biology, with measurable societal impact across biomedical research and education.

Profiles: Google Scholar | Scopus | ORCID

Featured Publications

Zamzami, N., Marchetti, P., Castedo, M., Decaudin, D., Macho, A., Hirsch, T., … Petit, P. X. (1995). Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death. The Journal of Experimental Medicine, 182(2), 367–377.

Zamzami, N., Marchetti, P., Castedo, M., Zanin, C., Vayssière, J. L., Petit, P. X., … Kroemer, G. (1995). Reduction in mitochondrial potential constitutes an early irreversible step of programmed lymphocyte death in vivo. The Journal of Experimental Medicine, 181(5), 1661–1672.

Kroemer, G., Petit, P., Zamzami, N., Vayssière, J. L., & Mignotte, B. (1995). The biochemistry of programmed cell death. The FASEB Journal, 9(13), 1277–1287.

Petit, P. X., Lecoeur, H., Zorn, E., Dauguet, C., Mignotte, B., & Gougeon, M. L. (1995). Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. The Journal of Cell Biology, 130(1), 157–167.

Petit, P. X., Susin, S. A., Zamzami, N., Mignotte, B., & Kroemer, G. (1996). Mitochondria and programmed cell death: Back to the future. FEBS Letters, 396(1), 7–13.

Dr. Petit’s work has fundamentally advanced our understanding of mitochondrial biology and programmed cell death, shaping modern concepts of apoptosis, autophagy, and cellular stress responses. His discoveries enabled new biomedical approaches to cancer, immunology, and rare diseases

Manar El-Morsy | Biochemistry, Genetics and Molecular Biology | Young Researcher Award

Published on by NESIN Awards

Dr . Manar El-Morsy | Biochemistry, Genetics and Molecular Biology | Young Researcher Award

Junior research at Faculty of Nanotechnology, Cairo University , Egypt

Manar Taher El-Morsy is a highly promising candidate for the Young Researcher Award, demonstrating strong academic and research capabilities in biotechnology and nanotechnology. Her innovative work on pH-sensitive nano-niosomes and grafted chitosan nanoparticles for targeted breast cancer therapy highlights her contribution to cutting-edge cancer treatment. With publications in Q1 journals, active participation in national conferences, and awards in scientific competitions, she has established herself as a driven and impactful researcher. Manar also engages in science communication as a medical writer and mentors students in research methodologies, showcasing leadership and dedication to scientific development. Her interdisciplinary projects span medical, environmental, and agricultural biotechnology, reflecting versatility and a commitment to sustainable solutions. While she would benefit from greater international exposure and advancing her English proficiency, her strong technical skills, research impact, and proactive engagement make her a highly suitable candidate for the award, with significant potential for future contributions to global science.

Professional Profile 

Education🎓

Manar Taher El-Morsy holds a Bachelor of Science degree in Biotechnology and Molecular Biology from the Faculty of Science, Cairo University, where she graduated with a “Very Good” academic standing. She is currently pursuing a Master’s degree in Bio-Nanotechnology at the Faculty of Nanotechnology, Cairo University, demonstrating her continued commitment to advanced scientific research and specialization. Throughout her academic journey, she has actively participated in scientific projects, receiving multiple certificates of completion from institutions such as Nile University and MSA University. Her education has been enriched by practical training in molecular biology techniques, nanomaterial synthesis, and bioinformatics, which she received from various esteemed institutions, including the Children’s Cancer Hospital Egypt (57357) and the Faculty of Science, Cairo University. Additionally, she has complemented her academic education with soft skills and analytical reasoning courses, enhancing her communication, critical thinking, and problem-solving abilities. Her academic background provides a solid foundation for her research and scientific contributions.

Professional Experience📝

Manar Taher El-Morsy has built a strong professional foundation in biotechnology and nanotechnology through diverse roles in research, instruction, and science communication. Since 2021, she has worked as a freelance researcher, focusing on drug delivery systems, cancer therapy, and sustainable biotechnological applications. Her role as a medical writer since 2022 has involved authoring and co-authoring review articles in Q1 journals, demonstrating her ability to translate complex scientific content for academic audiences. She has also served as a research instructor, mentoring students in research methodologies and project execution. Currently, she works as a research assistant at the Animal Health Research Institute, contributing to applied scientific studies. Her professional experience is further supported by participation in national and international conferences, workshops, and competitions, showcasing her skills in presentation, collaboration, and innovation. Through these roles, she has demonstrated a strong commitment to advancing scientific research and sharing knowledge with both academic and public audiences.

Research Interest🔎

Manar Taher El-Morsy’s research interests lie at the intersection of biotechnology, nanotechnology, and cancer therapy, with a particular focus on developing innovative drug delivery systems. She is deeply engaged in exploring smart nanocarriers, such as pH-sensitive nano-niosomes and grafted chitosan nanoparticles, for targeted treatment of aggressive cancers like triple-negative breast cancer. Her work also extends to sustainable technologies, including microbial fuel cells for waste management and nanotechnology-based solutions in agriculture. Manar is passionate about utilizing natural extracts and biopolymers in nanomedicine to create more effective and eco-friendly therapeutic options. Additionally, she has a strong interest in bionanosensors, molecular biology techniques, and the integration of bioinformatics tools to enhance research outcomes. Her goal is to contribute to global health by advancing precision medicine and sustainable biotechnology solutions. This multidisciplinary approach reflects her commitment to solving real-world challenges through innovative and scientifically rigorous research.

Award and Honor🏆

Manar Taher El-Morsy has received several prestigious awards and honors that reflect her academic excellence, research innovation, and leadership potential. She won 1st Place in the National Biotechnology Competition “Science Operation Leaders” (SOLE) in Egypt, recognizing her outstanding scientific knowledge and problem-solving skills. She also earned 1st Place in the Giza Governorate Short Story Writing Competition, highlighting her strength in scientific and creative communication. Manar was awarded multiple certificates of completion for her scientific projects at Cairo University, MSA University, and Nile University, where her research on pH-sensitive nano-niosomes was recognized. She was also a participant in the INJAZ Al Arab Competition in Dubai, showcasing her work on entrepreneurship and innovation. In addition, she received recognition from the Armed Forces’ BIC Competition and participated in the AgriTech4Egypt Innovation Challenge Bootcamp. These accolades collectively underscore her commitment to scientific advancement, interdisciplinary collaboration, and societal impact through research and innovation.

Research Skill🔬

Manar Taher El-Morsy possesses a diverse and advanced set of research skills that support her work in biotechnology, nanotechnology, and cancer therapy. She is proficient in molecular biology techniques such as PCR, DNA/RNA extraction, and gel electrophoresis, which are fundamental to her experimental work. In nanotechnology, she excels in the synthesis and characterization of nanomaterials and polymers, skills crucial for developing innovative drug delivery systems. Manar is also skilled in scientific writing and experimental design, allowing her to effectively communicate complex research findings in high-impact journals. Her bioinformatics training enhances her ability to analyze biological data, supporting data-driven decision-making in research. She has demonstrated competence in designing and implementing independent and collaborative projects, mentoring students, and presenting at national conferences. Her ability to integrate technical expertise with analytical thinking, problem-solving, and strong communication makes her a capable and innovative researcher dedicated to advancing science and addressing real-world challenges.

Conclusion💡

Manar Taher El-Morsy demonstrates exceptional promise as a young scientist. Her research is innovative, multidisciplinary, and impactful, particularly in areas such as cancer nanomedicine and sustainable biotechnology. She is actively engaged in scientific dissemination, mentoring, and leadership activities.

Given her trajectory, strong academic and publication record, and commitment to advancing science in Egypt and beyond, she is a compelling candidate for the Young Researcher Award, with only minor areas to refine for even broader recognition.

Publications Top Noted✍

  • Title: Metal–organic frameworks in drug delivery: engineering versatile platforms for therapeutic applications
    Authors: DSR Khafaga, MT El-Morsy, H Faried, AH Diab, S Shehab, AM Saleh, …
    Year: 2024
    Citations: 25

  • Title: Targeting tumor-associated macrophages with nanocarrier-based treatment for breast cancer: A step toward developing innovative anti-cancer therapeutics
    Authors: G Muteeb, DSR Khafaga, MT El-Morsy, M Farhan, M Aatif, M Hosney
    Year: 2024
    Citations: 4

  • Title: Herbal Medicine: Enhancing the Anticancer Potential of Natural Products in Hepatocellular Carcinoma Therapy Through Advanced Drug Delivery Systems
    Authors: G Muteeb, MT El-Morsy, MA Abo-Taleb, SK Mohamed, DSR Khafaga
    Year: 2024
    Citations: Not listed (assumed 0 or pending indexing)

 

 

 

Hao Wu | Protein engineering | Best Researcher Award

Published on by NESIN Awards

Assoc. Prof. Dr. Hao Wu | Protein engineering | Best Researcher Award

Teacher  at Changsha University of Science and Technology, China

Dr. Hao Wu is a highly qualified researcher with a Ph.D. in Microbiology and extensive postdoctoral experience. Currently serving as an Associate Professor at Changsha University of Science & Technology, his research focuses on food biotechnology, protein engineering, and synthetic biology, particularly in the development of anti-diabetic compounds, enzyme engineering, and the production of human milk oligosaccharides. With over 20 publications in high-impact journals and leadership in numerous first-author and corresponding author roles, Dr. Wu has made significant contributions to applied food science and biotechnology. His work on enzyme stability and microbial fermentation has direct industrial and health-related implications. Additionally, he is actively involved in peer review and editorial positions for several prestigious journals. While his profile would benefit from further recognition through awards and major project leadership, his impressive publication record and research contributions make him a strong contender for the Best Researcher Award.

Professional Profile 

Education🎓

Dr. Hao Wu holds a Ph.D. in Microbiology, which he earned in 2019 from Guangxi University in Nanning, Guangxi, China. He also completed his Bachelor of Science in Bioengineering at Guangxi University in 2013. His academic background provides a solid foundation for his current research, bridging microbiology, biotechnology, and food science. During his doctoral studies, Dr. Wu specialized in the molecular aspects of food biotechnology and protein engineering, laying the groundwork for his postdoctoral research at Jiangnan University. This advanced training has been crucial in shaping his research focus on the production of anti-diabetic compounds, enzyme modification, and synthetic biology applications. Throughout his academic journey, Dr. Wu has gained a strong grasp of both theoretical and practical aspects of bioengineering, allowing him to make significant contributions to the field of food biotechnology. His educational path reflects a deep commitment to advancing the understanding of microbiology and food science.

Professional Experience📝

Dr. Hao Wu has a rich professional background, combining research and teaching roles in the field of food biotechnology. After completing his Ph.D., he gained postdoctoral experience at Jiangnan University, where he advanced his research in protein engineering and microbial fermentation techniques. In December 2021, Dr. Wu joined Changsha University of Science & Technology as an Associate Professor in the School of Food Science and Bioengineering, where he has continued his research on food biotechnology, synthetic biology, and enzyme engineering. His work focuses on developing innovative solutions such as producing anti-diabetic compounds through microbial fermentation and engineering enzymes for the production of functional sugars and sugar alcohols. Dr. Wu’s role as a professor also involves mentoring graduate students and contributing to the university’s research initiatives. His experience as a peer reviewer and editorial board member for numerous scientific journals further highlights his active engagement in the scientific community.

Research Interest🔎

Dr. Hao Wu’s research interests are centered around food biotechnology, protein engineering, fermentation engineering, and synthetic biology. His work focuses on the development of potential anti-diabetic compounds through microbial fermentation techniques, employing methods such as microbial mutation breeding and fermentation process control. Additionally, Dr. Wu is dedicated to the molecular modification of enzymes, particularly in improving their thermal stability, catalytic activity, and substrate specificity for the production of functional sugars and sugar alcohols. Another key area of his research involves using cutting-edge synthetic biological technologies, including gene editing and metabolic engineering, to design and construct efficient cell factories for producing human milk oligosaccharides. His innovative approaches aim to address pressing challenges in the food industry, including the creation of healthier food ingredients and more sustainable production methods. Dr. Wu’s interdisciplinary expertise allows him to make significant contributions to both the scientific community and the applied biotechnology sector.

Award and Honor🏆

Dr. Hao Wu has earned several notable awards and honors throughout his academic and professional career, reflecting his outstanding contributions to the fields of food biotechnology and microbiology. As a leading researcher in the production of functional food ingredients and enzyme engineering, he has gained recognition for his innovative work, particularly in developing anti-diabetic compounds through microbial fermentation and engineering enzymes with improved properties. His research has been widely published in prestigious journals, and his work has attracted significant attention from the scientific community. Dr. Wu’s leadership extends beyond research, as he serves as a peer reviewer for numerous scientific journals, such as Journal of Agricultural and Food Chemistry and Critical Reviews in Food Science and Nutrition. His expertise has also led to editorial roles, including membership on the editorial boards of Food Science and Human Wellness and Journal of Future Foods, further demonstrating his respected status in the field.

Research Skill🔬

Dr. Hao Wu possesses a diverse set of research skills that have significantly contributed to his success in food biotechnology and microbiology. His expertise spans several advanced techniques, including microbial fermentation, protein engineering, and enzyme modification. Dr. Wu is proficient in employing microbial mutation breeding and fermentation process control to produce bioactive compounds, particularly for anti-diabetic applications. His work in molecular modification of enzymes focuses on improving their thermal stability, catalytic activity, and substrate specificity, using cutting-edge approaches like computational design and rational engineering. In addition, Dr. Wu is well-versed in synthetic biology techniques, such as gene editing and metabolic engineering, which he uses to design high-efficiency cell factories for the production of human milk oligosaccharides. His ability to integrate various biotechnological methodologies, along with his comprehensive understanding of biochemistry, enables him to address complex challenges and make innovative contributions to both the scientific community and the food industry.

Conclusion💡

Dr. Hao Wu is a strong candidate for the Best Researcher Award, particularly due to his:

  • High-quality publications,

  • Pioneering work in enzyme and metabolic engineering,

  • Leadership in synthetic biology applications for food science, and

  • Active contribution to the academic community through editorial roles.

If complemented by evidence of major grant leadership, mentorship of young researchers, and international academic visibility, his candidacy would be even more compelling.

Publications Top Noted✍️

  • Research Progress on the Preparation and Function of Antioxidant Peptides from Walnuts

    • Authors: Yuxi Hu, Ce Ni, Yingying Wang, Xun Yu, Hao Wu, Jia Tu, Changzhu Li, Zhihong Xiao, Li Wen

    • Year: 2023

    • Citation: International Journal of Molecular Sciences, DOI: 10.3390/ijms241914853

  • D-allulose, a Versatile Rare Sugar: Recent Biotechnological Advances and Challenges

    • Authors: Wenli Zhang, Ding Chen, Jiajun Chen, Wei Xu, Qiuming Chen, Hao Wu, Cuie Guang, Wanmeng Mu

    • Year: 2023

    • Citation: Critical Reviews in Food Science and Nutrition, DOI: 10.1080/10408398.2021.2023091

  • Engineering the Thermostability of D-lyxose Isomerase from Caldanaerobius Polysaccharolyticus via Multiple Computer-Aided Rational Design for Efficient Synthesis of D-Mannose

    • Authors: Hao Wu, Ming Yi, Xiaoyi Wu, Yating Ding, Minghui Pu, Li Wen, Yunhui Cheng, Wenli Zhang, Wanmeng Mu

    • Year: 2023

    • Citation: Synthetic and Systems Biotechnology, DOI: 10.1016/j.synbio.2023.04.003

  • Overview of Strategies for Developing High Thermostability Industrial Enzymes: Discovery, Mechanism, Modification and Challenges

    • Authors: Hao Wu, Qiuming Chen, Wenli Zhang, Wanmeng Mu

    • Year: 2023

    • Citation: Critical Reviews in Food Science and Nutrition, DOI: 10.1080/10408398.2021.1970508

  • Alanine Substitution to Determine the Effect of LR5 and YR6 Rice Peptide Structure on Antioxidant and Anti-Inflammatory Activity

    • Authors: Yun-Hui Cheng, Bu-Qing Liu, Bo Cui, Li Wen, Zhou Xu, Mao-Long Chen, Hao Wu

    • Year: 2023

    • Citation: Nutrients, DOI: 10.3390/nu15102373

  • Recent Development of Phenyllactic Acid: Physicochemical Properties, Biotechnological Production Strategies and Applications

    • Authors: Hao Wu, Cuie Guang, Wenli Zhang, Wanmeng Mu

    • Year: 2023

    • Citation: Critical Reviews in Biotechnology, DOI: 10.1080/07388551.2021.2010645

  • Application Prospects and Opportunities of Inorganic Nanomaterials for Enzyme Immobilization in the Food-Processing Industry

  • Glycosyltransferase from Bacteroides Gallinaceum Is a Novel α-1,3-Fucosyltransferase That Can Be Used for 3-Fucosyllactose Production In Vivo by Metabolically Engineered Escherichia Coli

    • Authors: Geng Chen, Hao Wu, Yingying Zhu, Li Wan, Wenli Zhang, Wanmeng Mu

    • Year: 2022

    • Citation: Journal of Agricultural and Food Chemistry, DOI: 10.1021/acs.jafc.1c06719

  • D-Mannose-Producing Isomerases and Epimerases: Properties, Comparisons, and Different Strategies

  • L-Arabinose Isomerase: Sources, Biochemical Properties, and Its Use to Produce D-Tagatose

  • Engineering Escherichia Coli for Highly Efficient Production of Lacto-N-triose II from N-acetylglucosamine, the Monomer of Chitin

  • Efficient Control of Acrylamide in French Fries by an Extraordinarily Active and Thermo-Stable L-Asparaginase: A Lab-Scale Study

  • Microbial Production, Molecular Modification, and Practical Application of L-Asparaginase: A Review

  • Metabolic Engineering of Escherichia Coli for Efficient Biosynthesis of Lacto-N-tetraose Using a Novel β-1,3-Galactosyltransferase from Pseudogulbenkiania Ferrooxidans

  • Metabolic Engineering of Escherichia Coli for Lacto-N-triose II Production with High Productivity

Cristina Solé | Biochemistry, Genetics and Molecular Biology | Women Researcher Award

Published on by NESIN Awards

Dr. Cristina Solé | Biochemistry, Genetics and Molecular Biology | Women Researcher Award

Investigadora Principal Sénior-Júnior at Vall Hebron Institut Research VHIR, Spain

Dr. Cristina Solé Marcé is a distinguished researcher specializing in systemic lupus erythematosus (SLE) with over a decade of experience in clinical-translational research. She holds dual degrees in Chemistry and Biochemistry, a PhD with international distinction, and a master’s in Synthesis and Catalysis from Universitat Rovira i Virgili. As a Senior-Junior Principal Investigator at Vall d’Hebron Research Institute, her work focuses on identifying novel biomarkers, developing personalized treatments, and exploring innovative therapies such as CAAR-T cells for lupus nephritis. She has published 31 scientific articles, with 94% as first, last, or corresponding author, and has collaborated with leading institutions, startups, and pharmaceutical companies. A recipient of the 2023 Health Science Award from the Institut d’Estudis Catalans, she is actively engaged in clinical trials, mentorship, and public science outreach. Dr. Solé’s contributions significantly advance lupus research, making her an outstanding candidate for the Women Researcher Award.

Professional Profile 

Education

Dr. Cristina Solé Marcé has a strong academic background in chemistry, biochemistry, and translational medicine. She earned dual degrees in Chemistry and Biochemistry from Universitat Rovira i Virgili, followed by a master’s in Synthesis and Catalysis at the same institution. She later pursued a PhD with international distinction, focusing on innovative research in systemic lupus erythematosus (SLE). Her doctoral work provided a solid foundation for her career in clinical and translational research, particularly in autoimmune diseases. Committed to continuous learning, Dr. Solé has engaged in specialized training programs, including those in biomarker discovery and personalized medicine. Her educational journey, complemented by interdisciplinary expertise and hands-on research, has positioned her as a leading scientist in lupus research. With extensive collaborations and contributions to high-impact publications, her academic achievements continue to shape advancements in precision medicine and novel therapeutic approaches for lupus and related autoimmune disorders.

Professional Experience

Dr. Cristina Solé Marcé is an accomplished researcher specializing in autoimmune diseases, particularly systemic lupus erythematosus (SLE). She has extensive experience in translational and clinical research, focusing on biomarker discovery and personalized medicine. Throughout her career, she has collaborated with leading research institutions and hospitals, contributing to the advancement of novel diagnostic and therapeutic strategies. Dr. Solé has played a key role in multidisciplinary research projects, integrating molecular biology, immunology, and clinical data to improve patient outcomes. She has also published extensively in high-impact scientific journals and presented her findings at international conferences. Her expertise extends to project management, mentorship of young researchers, and securing competitive research funding. Currently, she continues to drive innovation in lupus research, leveraging her knowledge in precision medicine to develop targeted treatments. Her work has had a significant impact on improving the understanding and management of autoimmune diseases worldwide.

Research Interest

Dr. Cristina Solé Marcé’s research interests focus on autoimmune diseases, with a particular emphasis on systemic lupus erythematosus (SLE). Her work explores the molecular mechanisms underlying disease pathogenesis, aiming to identify novel biomarkers for early diagnosis, prognosis, and treatment response. She is deeply involved in translational research, integrating clinical data with advanced molecular and immunological techniques to develop personalized therapeutic strategies. Dr. Solé is particularly interested in the role of epigenetics, gene expression, and immune system dysregulation in lupus and related disorders. Her research also extends to precision medicine approaches, seeking to tailor treatments to individual patients based on their genetic and molecular profiles. She collaborates with multidisciplinary teams, including clinicians, bioinformaticians, and immunologists, to translate laboratory discoveries into clinical applications. Through her work, Dr. Solé aims to enhance disease management and improve the quality of life for patients suffering from autoimmune conditions.

Award and Honor

​Dr. Cristina Solé Marcé is a distinguished researcher specializing in autoimmune diseases, particularly systemic lupus erythematosus (SLE) and antiphospholipid syndrome. Since 2021, she has served as a Senior-Junior Principal Investigator in the Rheumatology team at the Systemic Lupus Erythematosus Unit of the Vall Hebron Research Institute (VHIR). Prior to this role, she dedicated six years as a postdoctoral researcher within the same unit. Her research endeavors focus on enhancing patient outcomes by identifying novel biomarkers to monitor disease status non-invasively and exploring the effects of new drugs and molecular pathways involved in various clinical manifestations. This work has led to multiple publications in internationally recognized journals and invitations to present at prestigious conferences such as the American College of Rheumatology (ACR) and the European Alliance of Associations for Rheumatology (EULAR).

Research Skill

Dr. Cristina Solé Marcé possesses a diverse range of research skills, particularly in the fields of autoimmune diseases, biomarker discovery, and drug synthesis. She has extensive experience in molecular biology techniques, biochemical assays, and analytical chemistry, which she applies to her studies on systemic lupus erythematosus (SLE) and antiphospholipid syndrome. Her expertise includes non-invasive biomarker identification to improve disease monitoring and understanding the mechanisms of action of novel therapeutic agents. With a strong background in synthetic chemistry, she has worked on the enantioselective synthesis of drugs and the development of anticancer compounds. Additionally, she is skilled in experimental design, data analysis, and scientific communication, with multiple publications in high-impact journals and presentations at international conferences such as ACR and EULAR. Her interdisciplinary approach, combining chemistry, biochemistry, and immunology, enables her to contribute significantly to translational research and patient-centered advancements in rheumatology.

Conclusion

Dr. Cristina Solé Marcé is a highly accomplished researcher with an impressive track record in autoimmune disease research, particularly lupus. Her combination of scientific excellence, leadership, international collaboration, and patient engagement makes her a compelling candidate for the Women Researcher Award. Strengthening her funding profile and expanding her research applications could further solidify her impact. Given her current achievements, she is well-deserving of recognition through this award.

Publications Top Noted

  • Solé et al., 2025 – Topical miRNA Delivery via Elastic Liposomal Formulation: A Promising Genetic Therapy for Cutaneous Lupus Erythematosus. Int. J. Mol. Sci. DOI: 10.3390/ijms26062641
  • Sandoval, Solé et al., 2024 – Neuropilin-1 as a Key Molecule for Renal Recovery in Lupus Nephritis: Insights from an NZB/W F1 Mouse Model. Int. J. Mol. Sci. DOI: 10.3390/ijms252111364
  • Solé et al., 2024 – Precise Targeting of Autoantigen-Specific B Cells in Lupus Nephritis with Chimeric Autoantibody Receptor T Cells. Int. J. Mol. Sci. DOI: 10.3390/ijms25084226
  • Solé et al., 2023 – Small-Extracellular-Vesicle-Derived miRNA Profile Identifies miR-483-3p and miR-326 as Regulators in the Pathogenesis of Antiphospholipid Syndrome (APS). Int. J. Mol. Sci. DOI: 10.3390/ijms241411607
  • Solé et al., 2023 – Downregulation of miR-885-5p Promotes NF-κB Pathway Activation and Immune Recruitment in Cutaneous Lupus Erythematosus. J. Investig. Dermatol. DOI: 10.1016/j.jid.2022.08.036
  • Solé et al., 2022 – Humoral and Cellular Response in Convalescent COVID-19 Lupus Patients. Sci. Rep. DOI: 10.1038/s41598-022-17334-5
  • Domingo, Solé et al., 2021 – Thalidomide Exerts Anti-Inflammatory Effects in Cutaneous Lupus by Inhibiting the IRF4/NF-ҡB and AMPK1/mTOR Pathways. Biomedicines. DOI: 10.3390/biomedicines9121857
  • Domingo, Solé et al., 2020 – Efficacy of Thalidomide in Discoid Lupus Erythematosus: Insights into the Molecular Mechanisms. Dermatology. DOI: 10.1159/000508672
  • Domingo, Solé et al., 2020 – MicroRNAs in Several Cutaneous Autoimmune Diseases: Psoriasis, Cutaneous Lupus Erythematosus, and Atopic Dermatitis. Cells. DOI: 10.3390/cells9122656
  • Garcia-Vives, Solé et al., 2020 – The Urinary Exosomal miRNA Expression Profile is Predictive of Clinical Response in Lupus Nephritis. Int. J. Mol. Sci. DOI: 10.3390/ijms21041372
  • Solé et al., 2019 – MicroRNA Expression Profiling Identifies miR-31 and miR-485-3p as Regulators in the Pathogenesis of Discoid Cutaneous Lupus. J. Investig. Dermatol. DOI: 10.1016/j.jid.2018.07.026

Ze-Min Yang | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by NESIN Awards

Prof. Ze-Min Yang | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

College teachers at Guangdong Pharmaceutical University, China

Professor Ze-Min Yang is a distinguished researcher specializing in metabolic disease pathogenesis and pharmacological research integrating Traditional Chinese Medicine (TCM) with Western medicine. With over 40 academic publications, including 13 SCI-indexed papers, and three invention patents, he has made significant contributions to biomedical research. He has led multiple prestigious projects, including National Natural Science Foundation grants and provincial research collaborations, demonstrating strong leadership and innovation. Serving as Deputy Director at Guangdong Pharmaceutical University, he plays a key role in academic mentorship and scientific evaluation at the provincial level. His accolades, such as “Outstanding Science and Technology Worker” and “Outstanding Teacher,” further highlight his excellence. While his research output is impressive, enhancing international collaborations, increasing citation impact, and expanding interdisciplinary applications could further strengthen his global recognition. Overall, his achievements and leadership make him a strong candidate for the Best Researcher Award, recognizing his impactful contributions to science and medicine.

Professional Profile 

Education

Professor Ze-Min Yang has a strong academic foundation spanning multiple disciplines. He earned his Ph.D. in 2012 from the Institute of Spleen and Stomach Research at Guangzhou University of Traditional Chinese Medicine, specializing in integrated traditional Chinese and Western medicine clinical practice. Prior to this, he obtained a Master’s degree in Hydrobiology from the Hydrobiology Research Center of Jinan University in 2005, demonstrating his expertise in biological sciences. His academic journey began with a Bachelor’s degree in Freshwater Fisheries from the Department of Fisheries at Southwest Agricultural University in 2002. This diverse educational background has provided him with a unique interdisciplinary perspective, integrating biomedical sciences, traditional medicine, and hydrobiology. His advanced training and research experience have contributed to his expertise in metabolic disease pathogenesis and pharmacological research, reinforcing his position as a leading academic in the field of biomedical and pharmaceutical sciences.

Professional Experience

Professor Ze-Min Yang has an extensive professional background in biomedical and pharmaceutical sciences. He currently serves as a faculty member in the Department of Biochemistry and Molecular Biology at the School of Basic Medical Sciences, Guangdong Pharmaceutical University. Additionally, he holds the position of Deputy Director of the Experimental Teaching Center, where he plays a key role in advancing scientific research and education. His expertise is recognized at the provincial level, as he actively contributes as an expert in science and technology project evaluation and acceptance for both Guangdong Province and Guangzhou City. Throughout his career, he has led multiple prestigious research projects, including those funded by the National Natural Science Foundation and Guangdong Provincial Science and Technology Department. His leadership in academic research, combined with his contributions to scientific evaluation and mentorship, underscores his dedication to advancing biomedical sciences and fostering innovation in traditional Chinese and Western medicine integration.

Research Interest

Professor Ze-Min Yang’s research interests focus on the pathogenesis of metabolic diseases and the pharmacological effects of integrating Traditional Chinese Medicine (TCM) with Western medicine. His work explores innovative approaches to understanding and treating metabolic disorders through a combination of molecular biology, biochemistry, and traditional herbal medicine. He is particularly interested in identifying bioactive compounds in TCM that can be used for drug development and disease management. His interdisciplinary research extends to studying the mechanisms of metabolic regulation, inflammation, and gut microbiota interactions in disease progression. By bridging modern biomedical research with traditional healing practices, he aims to develop novel therapeutic strategies that are both scientifically validated and culturally relevant. His contributions, supported by multiple national and provincial research grants, significantly advance the integration of TCM with evidence-based medicine, enhancing its global recognition and application in modern healthcare.

Award and Honor

Professor Ze-Min Yang has received numerous awards and honors in recognition of his outstanding contributions to scientific research, education, and innovation. He has been honored with titles such as “Outstanding Science and Technology Worker,” “Advanced Teaching Worker,” and “Outstanding Teacher” by Guangdong Pharmaceutical University, reflecting his excellence in both research and academia. His leadership in biomedical sciences and commitment to integrating Traditional Chinese Medicine with Western medicine have earned him prestigious recognition at institutional and provincial levels. Additionally, his contributions as an expert in science and technology project evaluation for Guangdong Province and Guangzhou City highlight his influence in shaping research policies and advancements. With multiple funded projects, over 40 academic publications, and three invention patents, his work has significantly impacted the field of metabolic disease research. These accolades reinforce his reputation as a distinguished scientist and educator, making him a strong candidate for prestigious research awards.

Research Skill

Professor Ze-Min Yang possesses a diverse and advanced set of research skills, particularly in the fields of biochemistry, molecular biology, and pharmacology. His expertise lies in investigating the pathogenesis of metabolic diseases and the therapeutic potential of Traditional Chinese Medicine (TCM) integrated with Western medicine. He has extensive experience in experimental design, data analysis, and clinical applications, allowing him to bridge theoretical research with practical medical solutions. His work involves drug discovery, biomarker identification, and molecular mechanism studies, utilizing cutting-edge laboratory techniques such as cell culture, gene expression analysis, and bioinformatics. Additionally, his ability to lead multi-disciplinary research projects, secure national and provincial funding, and collaborate with experts in biomedical sciences demonstrates his strong project management and leadership skills. His contributions, including over 40 academic publications and three patents, highlight his ability to drive innovative research that advances both scientific knowledge and clinical applications.

Conclusion

Professor Ze-Min Yang is a strong candidate for the Best Researcher Award due to his extensive research in metabolic diseases, leadership in TCM and Western medicine integration, multiple prestigious grants, and significant academic contributions. To further enhance his profile, international collaborations, higher-impact publications, and broader interdisciplinary work would strengthen his candidacy.

Publications Top Noted

  • Title: “Identification of microRNA and analysis of target genes in Panax ginseng”

    Authors: Yingfang Wang, Yanlin Chen, Mengyuan Peng, Yongqin Yin, Yu Zeng

    Year: 2023

    Citations: 8

    Source: Chinese Herbal Medicines

  • Title: “Astragalus Polysaccharides Alleviate Type 2 Diabetic Rats by Reversing the Expressions of Sweet Taste Receptors and Genes Related to Glycolipid Metabolism in Liver”

    Authors: Mengjuan Luo, Ying Wang, Siyu Chen, Zemin Yang

    Year: 2022

    Citations: 14

    Source: Frontiers in Pharmacology

Janne Rojas | Chemistry | Women Researcher Award

Published on by NESIN Awards

Dr. Janne Rojas | Chemistry | Women Researcher Award

Profesora investigadora at Universidad de Los Andes, Venezuela

Dr. Janne del Carmen Rojas Vera is a distinguished Venezuelan researcher and professor at the Faculty of Pharmacy, Universidad de Los Andes (ULA), specializing in natural products and medicinal chemistry. She holds a Ph.D. from the University of Portsmouth, England, and a Master’s in Medicinal Chemistry from ULA. With over three decades of academic and research experience, she has contributed significantly to the study of bioactive compounds, antimicrobial activity, and phytochemical properties of medicinal plants. As a full professor and research mentor, she has guided numerous undergraduate, master’s, and doctoral theses. Her work has led to multiple scientific publications in international journals, showcasing her expertise in pharmacognosy and pharmaceutical sciences. Dr. Rojas’s dedication to advancing scientific knowledge and training future researchers makes her a strong candidate for the Women Researcher Award, recognizing her impactful contributions to medicinal chemistry and her commitment to innovation in pharmaceutical research.

Professional Profile

Education

Dr. Janne del Carmen Rojas Vera has an extensive academic background in pharmaceutical sciences and medicinal chemistry. She earned her Doctor of Philosophy (Ph.D.) in 2002 from the University of Portsmouth, England, where she conducted research on the chemical and pharmacological properties of raspberry leaf (Rubus idaeus). Prior to that, she completed a Master of Science in Medicinal Chemistry at the Universidad de Los Andes (ULA), Mérida, Venezuela, in 1995. Her academic journey began with a Bachelor’s degree in Pharmacy from ULA in 1990, where she graduated with distinction, securing third place in her graduating class. Her specialized training and advanced studies have equipped her with expertise in organic chemistry, natural products, and pharmacognosy. With a strong foundation in both theoretical and applied pharmaceutical sciences, Dr. Rojas has continued to contribute to research, innovation, and education in the field, mentoring students and leading scientific investigations in medicinal chemistry.

Professional Experience

Dr. Janne del Carmen Rojas Vera has over three decades of professional experience in pharmaceutical research and academia. She has been a dedicated faculty member at the Universidad de Los Andes (ULA), Venezuela, since 1992, progressively advancing through academic ranks to become a Full Professor in 2011. Specializing in medicinal chemistry and natural products, she has taught courses at both undergraduate and postgraduate levels, including Organic Chemistry, Natural Products, and Medicinal Chemistry. Her research focuses on the chemical and pharmacological properties of bioactive compounds, leading to numerous scientific publications. In addition to her teaching and research, Dr. Rojas has mentored many undergraduate, master’s, and doctoral students, fostering new generations of scientists. She also served as a pharmacist early in her career, gaining practical expertise in drug analysis. Her extensive experience in education, research, and mentorship highlights her invaluable contributions to pharmaceutical sciences and academia.

Research Interests

Dr. Janne del Carmen Rojas Vera’s research interests lie in the fields of medicinal chemistry, natural products, and pharmaceutical sciences. Her work focuses on the isolation, characterization, and pharmacological evaluation of bioactive compounds derived from medicinal plants, particularly those with antibacterial, antioxidant, and cytotoxic properties. She is dedicated to studying the chemical composition of essential oils and plant extracts to explore their potential therapeutic applications. Dr. Rojas has contributed significantly to understanding the biological activities of various plant species, aiming to discover novel compounds with pharmaceutical relevance. Her research extends to evaluating the toxicity, analgesic effects, and antimicrobial properties of natural products, providing valuable insights into drug discovery. She also investigates phytochemical screening.

Awards and Honors

Dr. Janne del Carmen Rojas Vera has received numerous awards and honors in recognition of her outstanding contributions to pharmaceutical sciences, medicinal chemistry, and natural product research. As a distinguished academic, she earned third place in student performance ranking during her undergraduate studies in pharmacy at the Universidad de Los Andes. Throughout her career, she has been acknowledged for her dedication to scientific research, particularly in the study of bioactive compounds and their pharmaceutical applications. Her research has been published in prestigious scientific journals, further cementing her reputation in the field. Dr. Rojas has also been honored for her mentorship and commitment to training future researchers in pharmaceutical sciences. Her involvement in various research projects, coupled with her leadership in academia, has made her a respected figure in the scientific community. These accolades highlight her significant impact on advancing medicinal chemistry and natural product research.

Research Skills

Dr. Janne del Carmen Rojas Vera possesses a diverse and advanced skill set in pharmaceutical and natural product research. Her expertise includes phytochemical analysis, isolation, and structural elucidation of bioactive compounds, particularly from medicinal plants. She is highly skilled in chromatographic techniques such as HPLC, GC-MS, and TLC, which are essential for the qualitative and quantitative analysis of natural products. Additionally, Dr. Rojas specializes in pharmacological and antimicrobial activity assessments, evaluating the therapeutic potential of plant-derived compounds against various pathogens. Her research skills extend to spectroscopic methods, including NMR and UV-Vis spectroscopy, for the identification of chemical constituents. As a seasoned academic, she excels in designing and supervising research projects, guiding students in experimental methodologies, and publishing scientific findings in high-impact journals. Her ability to integrate chemistry, pharmacology, and biotechnology in her research makes her a highly proficient and respected scientist in the field of medicinal chemistry.

Conclusion

Dr. Janne del Carmen Rojas Vera is a highly qualified candidate for the Women Researcher Award due to her extensive academic career, impactful research in medicinal chemistry, and dedication to mentoring future scientists. Her work in natural product research, antimicrobial studies, and pharmaceutical sciences has significantly contributed to her field. With further international collaborations and high-impact publications, she could further enhance her global research footprint.

Publication Top Notes

  • Rojas, J.D.C., Buitrago Díaz, A.A., Rojas-Fermín, L.B., Ramírez, H., & Fernandez-Moreira, E. (2024). Chemical composition and cytotoxic activity of the essential oil of Hinterubera imbricata species collected in Venezuelan Andes. Journal of Essential Oil-Bearing Plants.

  • Rojas, J.D.C., & Buitrago Díaz, A.A. (Year not available). Antimicrobial Activity of Essential Oils from Species Collected in Venezuelan Andean. [No source information available].

  • Bouzier, A., Rojas, J.D.C., Koumba, S., Martin, P., & Morillo Salcedo, M. (2023). The Impact of Saponins on Health-Review. Biointerface Research in Applied Chemistry.

  • Rojas, J.D.C., Ndong-Ntoutoume, G.M.A., Martin, P., & Morillo Salcedo, M. (2021). Antibacterial activity and reversal of multidrug resistance of tumor cells by essential oils from fresh leaves, flowers, and stems of Montanoa quadrangularis Schultz Bipontinus (Asteraceae) collected in Mérida—Venezuela. Biomolecules.

Ahmet Altay | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by NESIN Awards

Assoc. Prof. Dr. Ahmet Altay | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Erzincan Üniversitesi, Turkey

Dr. Ahmet Altay is an accomplished researcher and academic in the field of chemistry, specializing in biochemistry, medicinal chemistry, and interdisciplinary sciences. With a strong background in natural product chemistry and anticancer drug discovery, he has contributed significantly to the scientific community through his research on antioxidants, cytotoxic agents, and enzyme inhibition. His extensive publication record in high-impact SCI-Expanded journals highlights his expertise in experimental and computational studies. Currently serving as an Associate Professor at Erzincan Binali Yıldırım University, Dr. Altay continues to push the boundaries of chemical and biochemical research, focusing on novel therapeutic compounds and their biological applications.

Professional Profile 

Education

Dr. Ahmet Altay earned his Ph.D. in Biochemistry from Middle East Technical University (METU), Turkey, in 2015. His doctoral research focused on the antioxidant and cytotoxic properties of Salvia fruticosa M., as well as its effects on cytochrome P450 enzymes and antioxidant gene expression in colon cancer cells.

Professional Experience

Dr. Altay has been a faculty member at Erzincan Binali Yıldırım University since 2016. He started as an Assistant Professor (2016-2018), was promoted to Associate Professor in 2020, and has since been actively involved in research and teaching. His work spans multiple disciplines within chemistry and biochemistry, with a strong focus on drug discovery and molecular interactions. His contributions include supervising graduate students, securing research grants, and collaborating on international scientific projects.

Research Interests

Dr. Ahmet Altay’s research interests lie at the intersection of biochemistry, medicinal chemistry, and pharmacology, with a particular focus on drug discovery and natural product chemistry. His work extensively explores the antioxidant, anticancer, and enzyme-inhibitory properties of bioactive compounds derived from medicinal plants. He is also deeply engaged in molecular docking studies to understand drug-receptor interactions at a computational level. Additionally, his research investigates apoptosis mechanisms, oxidative stress-related disorders, and the modulation of key metabolic pathways in cancer and neurodegenerative diseases. By integrating experimental and computational approaches, Dr. Altay aims to develop novel therapeutic agents that can target cancer, microbial infections, and enzyme-related disorders. His interdisciplinary research combines chemical synthesis, molecular modeling, and pharmacological evaluation to provide innovative solutions in biomedical sciences.

Awards and Honors

Dr. Ahmet Altay has received multiple awards and recognitions for his outstanding contributions to scientific research and academia. His excellence in publishing high-impact research has been acknowledged with best paper awards and recognitions from international conferences and scientific organizations. He has been honored with research grants and funding support for his projects on natural product chemistry and drug discovery. As an active academic, he has also received accolades for his contributions to student mentorship and scientific collaboration. His efforts in cancer research and enzyme inhibition studies have been recognized by national and international institutions. Additionally, his role as a peer reviewer and editorial board member in prestigious scientific journals highlights his expertise and influence in the field. These awards and honors underscore his dedication to advancing biomedical and pharmaceutical sciences.

Research Skills

Dr. Ahmet Altay possesses a diverse set of research skills spanning experimental and computational methodologies. His expertise includes the isolation and structural characterization of bioactive natural products using advanced chromatographic and spectroscopic techniques such as HPLC, GC-MS, and NMR. He is highly proficient in molecular docking, molecular dynamics simulations, and in silico drug design to predict ligand-target interactions. His skills in biochemical assays enable the evaluation of antioxidant, antimicrobial, and anticancer activities of synthetic and natural compounds. Additionally, he has extensive experience in enzyme kinetics, apoptosis studies, and gene expression analysis using RT-PCR and Western blot techniques. His interdisciplinary knowledge allows him to integrate synthetic chemistry, pharmacology, and bioinformatics to address complex biomedical challenges. Dr. Altay’s strong analytical skills, coupled with his experience in mentoring and collaboration, make him a leading researcher in his field.

Conclusion

Dr. Ahmet Altay is a strong candidate for the Best Researcher Award due to his high research output, international collaborations, and contributions to anticancer and biochemical research. To enhance his profile further, he could focus on leading large-scale projects, securing more grants, and publishing in top-tier journals. Nonetheless, his achievements make him a compelling nominee for this award.

Publications Top Noted

  • Title: Diffractaic acid exerts anti-cancer effects on hepatocellular carcinoma HepG2 cells by inducing apoptosis and suppressing migration through targeting thioredoxin reductase 1

    • Authors: Emine Karaca Sulukoğlu, Şükran Günaydın, Şeyda Nur Kalın, Ahmet Altay, Harun Budak
    • Year: 2024
    • Citation: Naunyn-Schmiedeberg’s Archives of Pharmacology
    • DOI: 10.1007/s00210-024-02980-5

  • Title: The Combined Effect of Vulpinic Acid and Doxorubicin in Breast Cancer MCF-7 Cells

    • Authors: Esma Kübra Kağan Yeniçeri, Ahmet Altay
    • Year: 2024
    • Citation: Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi
    • DOI: 10.18185/erzifbed.1376859

  • Title: Diffractaic acid exhibits thioredoxin reductase 1 inhibition in lung cancer A549 cells

    • Authors: Şükran Günaydın, Emine Karaca Sulukoğlu, Şeyda Nur Kalın, Ahmet Altay, Harun Budak
    • Year: 2023
    • Citation: Journal of Applied Toxicology
    • DOI: 10.1002/jat.4505

  • Title: Effect of evernic acid on human breast cancer MCF‐7 and MDA‐MB‐453 cell lines via thioredoxin reductase 1: A molecular approach

    • Authors: Şeyda Nur Kalın, Ahmet Altay, Harun Budak
    • Year: 2023
    • Citation: Journal of Applied Toxicology
    • DOI: 10.1002/jat.4451

  • Title: In Vitro Cytotoxic Evaluation of a Silver(I) Complex Including Non-Steroidal Anti-Inflammatory Drug Niflumic Acid and 3-Picoline on Human-Derived Cancer Cell Lines

    • Authors: Sema Çağlar, Ahmet Altay, Bülent Çağlar, Esma Kübra Kağan Yeniçeri, Betül Harurluoğlu
    • Year: 2022
    • Citation: Erzincan Üniversitesi Fen Bilimleri Enstitüsü Dergisi
    • DOI: 10.18185/erzifbed.1130634

  • Title: A Biochemical Approach for Hedysarum candidissimum from Turkey: Screening Phytochemicals, Evaluation of Biological Activities, and Molecular Docking Study

    • Authors: Ahmet Altay, Esma Yeniceri, Parham Taslimi, Tugba Taskin‐Tok, Mustafa Abdullah Yilmaz, Ekrem Koksal
    • Year: 2022
    • Citation: Chemistry & Biodiversity
    • DOI: 10.1002/cbdv.202200348

  • Title: Phytochemical Analysis and Biological Evaluation of Hypericum linarioides Bosse: in Vitro and in Silico Studies

    • Authors: Ahmet Altay, Esma Kübra Kağan Yeniçeri, Parham Taslimi, Tugba Taskin‐Tok, Mustafa Abdullah Yılmaz, Ekrem Köksal
    • Year: 2022
    • Citation: ChemistrySelect
    • DOI: 10.1002/slct.202200039

Saliha Pathan | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Published on by NESIN Awards

Ms. Saliha Pathan | Biochemistry, Genetics and Molecular Biology | Best Researcher Award

Research Assistant at Baylor college of medicine, United States

Ms. Saliha Pathan is a dedicated research professional with extensive experience in molecular biology, cell culture, and translational biomedical research. Her technical expertise spans a wide array of laboratory techniques, including PCR, RT-PCR, CRISPR, CHIP-PCR, iPSC generation, and ELISA, among others. Saliha has been instrumental in investigating cellular and molecular mechanisms related to cardiac repair, inflammatory regulation, and metabolic reprogramming. With a proven track record of delivering high-quality research outputs, she has contributed to several impactful studies, published in leading journals like Scientific Reports and Journal of Cardiovascular Development and Disease. In addition to her technical acumen, she is a strong communicator, team player, and mentor, as demonstrated through her teaching assistantship and collaborative research efforts.

Professional profile

Education📚

Ms. Pathan earned her Master’s in Biological Sciences with a specialization in Cell and Molecular Biology from the University of Houston-Clear Lake in 2021. During this program, she honed her skills in molecular techniques and experimental design. She previously completed her B.Tech in Biotechnology from D.Y. Patil School of Biotechnology and Bioinformatics in 2018, where she gained a foundational understanding of biotechnological applications in research and healthcare. Her academic background laid a robust groundwork for her diverse professional pursuits, bridging theoretical knowledge and practical expertise.

Professional Experience🏛️

Currently, Ms. Pathan serves as a Research Assistant II at Baylor College of Medicine, focusing on cardiac cell reprogramming, stem cell generation, and advanced molecular techniques. Previously, she held the position of Research Assistant I at the same institution, where she conducted experiments on protein isolation, Western blotting, and mouse genotyping. Her earlier roles include working as a Teaching Assistant at the University of Houston-Clear Lake, where she trained students in molecular and microbiological methods, and as a Laboratory Assistant in Mumbai, India, performing sample analyses and documentation. She also gained clinical experience as a Physician Assistant and Pharmacy Technician, demonstrating her versatility and adaptability across domains.

Research Interest🌐

Ms. Pathan’s research interests revolve around regenerative medicine, cellular reprogramming, and inflammation biology. Her work focuses on exploring the molecular pathways involved in cardiac fibroblast transition and macrophage-mediated inflammatory responses. She is particularly interested in using advanced genetic tools like CRISPR and CHIP-PCR to unravel the mechanisms of cellular plasticity and disease progression. Furthermore, her contributions to translational research aim to bridge the gap between bench science and clinical applications, particularly in cardiac repair and liver injury models. Her passion for innovation and commitment to impactful research drive her continuous exploration of new scientific frontiers.

Awards and Honors🏆

Ms. Pathan’s research excellence has been recognized through various awards and honors. She received the Pediatric Research Symposium Oral Presentation Award in 2022 and was selected for poster presentations in subsequent years, including the 2023 Pediatric Research Symposium and the 2024 Liver Meeting. Her poster on cardiac fibroblast reprogramming was featured at the prestigious Michael E. DeBakey Department of Surgery Research Day. Beyond presentations, her collaborative efforts in grant writing contributed to securing a RO-1 grant. These accolades highlight her ability to present complex findings effectively and her dedication to advancing scientific knowledge.

Conclusion

Saliha Pathan is an exceptionally qualified candidate for the Best Researcher Award, backed by her extensive technical proficiency, impactful research contributions, and active role in the academic community. Her ability to effectively integrate molecular biology expertise with clinical applications and her history of awards and publications strongly position her as a top contender. Addressing the areas of improvement—such as pursuing independent funding and niche specialization—could elevate her profile even further for future awards.

Publications top noted📜
  • Title: P2Y2 purinergic receptor gene deletion protects mice from bacterial endotoxin and sepsis-associated liver injury and mortality
    Authors: AR Arunachalam, SS Samuel, A Mani, JP Maynard, KM Stayer, E Dybbro, S Pathan, et al.
    Year: 2023
    Citation: 6
  • Title: Sall4 and Gata4 induce cardiac fibroblast transition towards a partially multipotent state with cardiogenic potential
    Authors: H Gao, S Pathan, BREA Dixon, A Pugazenthi, M Mathison, et al.
    Year: 2024
    Citation: 1
  • Title: Activation of a GPCR, ORL1 receptor: A novel therapy to prevent heart failure progression
    Authors: SS Pathan, A Pugazenthi, BREA Dixon, TG Wensel, TK Rosengart, M Mathison
    Year: 2024
    Citation: 0
  • Title: Functional analysis of repositioned anilide derivatives as anticancer compounds
    Authors: M Parab, SS Pathan, RK Panesar, SS Chhajed, D Dasgupta, PP Gupta
    Year: 2022
    Citation: 0
  • Title: Functional analysis of repositioned anilide derivatives as anticancer compounds
    Authors: M Parab, S Pathan, RK Panesar, SS Chhajed, D Dasgupta, PP Gupta
    Year: 2022
    Citation: 0

Qianqian Zhuang | Molecular Biology | Best Researcher Award

Published on by NESIN Awards

Assoc. Prof. Dr. Qianqian Zhuang | Molecular Biology | Best Researcher Award

Assoc. Prof. Dr. at Qilu University of Technology (Shandong Academy of Sciences), China

Dr. Qianqian Zhuang is an accomplished Associate Professor at Qilu University of Technology (Shandong Academy of Sciences), Jinan, China. With extensive experience in the fields of synthetic biology, biochemical engineering, and biobased materials, she has made significant contributions to the advancement of sustainable biotechnologies. Her research primarily focuses on developing biotechnological processes for producing biodegradable plastics and other biobased materials through metabolic engineering. Throughout her career, she has been actively involved in national and international research projects, publications, and collaborations, demonstrating both academic excellence and a commitment to mentoring the next generation of scientists. Dr. Zhuang is a highly respected figure in her field, known for her research’s practical applications in industry and environmental sustainability.

Professional profile

Education📚

Dr. Qianqian Zhuang earned her Ph.D. in Microbiology in 2015 from Shandong University, China. She completed her doctoral research at the State Key Laboratory of Microbial Technology, focusing on metabolic engineering and synthetic biology, which laid the foundation for her future academic and research career. Dr. Zhuang’s rigorous education enabled her to acquire deep expertise in biochemistry, microbiology, and biotechnology, positioning her as a leader in the study of biobased materials and sustainable technology. Her advanced education also allowed her to contribute significantly to developing novel research methodologies, making her a valuable resource in both academia and industry.

Professional Experience🏛️

Dr. Zhuang’s professional career is marked by significant roles in both academia and research leadership. She currently serves as an Associate Professor at Qilu University of Technology (Shandong Academy of Sciences), where she leads multiple research projects in synthetic biology and biochemical engineering. Previously, Dr. Zhuang worked as a postdoctoral researcher at Shandong University of Traditional Chinese Medicine, where she expanded her knowledge in biotechnological applications. Her experience includes securing and leading national research grants, such as the National Natural Science Foundation of China and the Key Research and Development Program of Shandong Province, demonstrating her leadership in high-impact scientific initiatives.

Research Interest🌐

Dr. Zhuang’s primary research interests lie in synthetic biology, biochemical engineering, and the development of biobased materials. She focuses on the engineering of microorganisms for the production of polyhydroxyalkanoates (PHA) and other biopolymers from renewable resources, aiming to replace petrochemical-based plastics with sustainable alternatives. Her research also explores metabolic pathway engineering, including the use of Escherichia coli for the synthesis of medium-chain-length PHAs. Additionally, Dr. Zhuang investigates advancements in nanocomposites and sustainable technology solutions. Her work has implications for environmental sustainability, bio-based production processes, and renewable materials, contributing to the fields of industrial biotechnology and green chemistry.

Awards and Honors🏆

Dr. Zhuang has received several prestigious awards throughout her career. Notably, she was recognized as an “Outstanding Graduate” by both Shandong Province and Shandong University in 2015, a testament to her academic excellence and research contributions. Additionally, she has been honored as an Innovation and Entrepreneurship Mentor at Qilu University of Technology (Shandong Academy of Sciences), where she actively fosters innovation and guides young researchers. These accolades reflect her commitment to excellence in both research and mentorship, highlighting her impact on the scientific community and her role in advancing biotechnological innovations.

Conclusion🏅

Qianqian Zhuang demonstrates exemplary qualities as a researcher, educator, and mentor. Her research on sustainable biotechnologies and synthetic biology is both cutting-edge and applicable to solving critical global challenges such as environmental sustainability and industrial biotechnology. Her leadership in major research projects, impressive publication record, and academic honors make her a strong candidate for the Best Researcher Award. With some further expansion of her international collaborations and public outreach, she is likely to make even greater contributions to her field in the coming years.

Publications top noted📜

  1. Title: Reconstruction of the feedback regulation of amino acid metabolism to develop a non-auxotrophic l-threonine producing Corynebacterium glutamicum
    Authors: Liu, J., Liu, J., Li, J., … Zhu, D., Zheng, P.
    Year: 2024
    Citations: 2
  2. Title: Exploring the action mechanism of Gegensan in the treatment of alcoholic liver disease based on network pharmacology and bioinformatics
    Authors: Yang, J., Zhuang, Q., Tang, K., Liu, X.
    Year: 2024
    Citations: 0
  3. Title: Advancements in TiO2-based nanocomposites for sustainable technology solutions
    Authors: Zhuang, Q., Shi, K., Lou, Y., Zhou, H.
    Year: 2024
    Citations: 0
  4. Title: Active ingredient and mechanistic analysis of traditional Chinese medicine formulas for the prevention and treatment of COVID-19: Insights from bioinformatics and in vitro experiments
    Authors: Yang, J., Zhuang, Q., Zhang, C., Liu, X.
    Year: 2023
    Citations: 1
  5. Title: IFE based nanosensor composed of UCNPs and Fe(II)-phenanthroline for detection of hypochlorous acid and periodic acid
    Authors: Song, H., Zhou, H., Zhuang, Q., … Zhou, G., Zhao, Y.
    Year: 2023
    Citations: 5
  6. Title: STING activation promotes inflammatory response and delays skin wound healing in diabetic mice
    Authors: Feng, Z., Zang, C., Zhang, L., … Zhuang, Q., Wang, X.
    Year: 2022
    Citations: 12
  7. Title: Applied evolution: Dual dynamic regulations-based approaches in engineering intracellular malonyl-CoA availability
    Authors: Wu, J., Zhou, L., Duan, X., … Dong, M., Zhou, J.
    Year: 2021
    Citations: 20
  8. Title: Vertically aligned 1T-phase PtSe2 on flexible carbon cloth for efficient and stable hydrogen evolution reaction
    Authors: Zhang, L., Kong, D., Zhuang, Q., … Li, X., Huang, X.
    Year: 2021
    Citations: 13
  9. Title: Warm white-light emitting silica films prepared using lead-free double perovskite QDs
    Authors: Li, Z., Sun, F., Song, H., … Zhuang, Q., Yu, X.
    Year: 2021
    Citations: 10
  10. Title: Developing a pathway-independent and full-autonomous global resource allocation strategy to dynamically switching phenotypic states
    Authors: Wu, J., Bao, M., Duan, X., … Zhuang, Q., Zhao, Z.
    Year: 2020
    Citations: 30.

Sandrina Heleno | Biochemistry | Industry Innovation Recognition Award

Published on by NESIN Awards

Dr. Sandrina Heleno | Biochemistry | Industry Innovation Recognition Award

Investigador at Polytechnic University of Bragança, Portugal 

Dr. Sandrina Alves Heleno is an accomplished researcher in the field of food science and biotechnology, currently serving as an Assistant Researcher at the Mountain Research Centre (CIMO) and Associated Laboratory SusTEC in Portugal. With a strong academic background in Biotechnological Engineering, Biotechnology, and Chemistry, her work focuses on the extraction, identification, and application of bioactive compounds from natural sources. She has been involved in multiple national and international research projects, serving as Principal Investigator for several initiatives. Dr. Heleno has published over 100 papers, contributed to book chapters, and holds patents related to the development of natural preservatives and functional foods. Her work has gained industry recognition, leading to the creation of a spin-off company. She is also an Associate Editor for Frontiers in Nutrition. Dr. Heleno’s contributions have earned her a place among the top 2% most-cited researchers in the food sector globally.

Professional profile

Education📚

Dr. Sandrina Alves Heleno’s academic journey began with a degree in Biotechnological Engineering from the Instituto Politécnico de Bragança, Portugal, in 2008. She went on to complete her master’s degree in Biotechnology in 2010, with a thesis on the bioactive properties of wild mushrooms. In 2014, she earned her Ph.D. in Sciences (Chemistry) from the University of Minho, Portugal. Her doctoral research focused on the chemical synthesis of important human metabolites derived from phenolic acids and their antioxidant, antitumor, and antimicrobial properties. This work provided her with valuable insights into the metabolization of natural compounds and laid the foundation for her future research in food science and technology. Throughout her education, Dr. Heleno demonstrated a keen interest in bioactive compounds and their potential application in the food industry, setting the stage for her impactful career as a researcher and innovator in the field of natural bioactive molecules.

Professional Experience🏛️

Dr. Sandrina Alves Heleno has extensive experience in food science, biotechnology, and chemistry, with a focus on sustainable food production and the development of functional bioactive ingredients. She began her career with a postdoctoral research grant from Fundação para a Ciência e a Tecnologia (FCT) in 2015, which led to her appointment as an Assistant Researcher at CIMO and the Associated Laboratory SusTEC. Throughout her career, Dr. Heleno has led multiple research projects funded by national and international bodies, with a particular emphasis on identifying, recovering, and applying functional molecules in the food industry. She has served as Principal Investigator for four funded research projects and has been involved in collaborations with renowned enterprises and research centers. Dr. Heleno has also contributed to knowledge transfer, fostering collaborations between academia and industry. Her leadership extends to her role as the head of the Food&Biotech research group at CIMO/SusTEC.

Research Interest🌐

Dr. Sandrina Alves Heleno’s research interests lie in the intersection of food science, biotechnology, and sustainable agriculture. Her primary focus is on the identification, extraction, and application of bioactive compounds from natural matrices, including plants, mushrooms, and other agricultural by-products. She is particularly interested in exploiting these compounds for their antioxidant, antitumor, and antimicrobial properties and incorporating them into functional foods and natural preservatives. Dr. Heleno’s work also explores greener and more sustainable processes for the recovery of high-value molecules, aiming to optimize their stability for industrial applications. Another key area of her research is the development of biofungicides and natural antimicrobials, with a specific focus on the agrifood sector. Dr. Heleno’s dedication to promoting the transfer of research from academia to industry ensures that her findings contribute to real-world solutions in food technology and sustainable food production.

Awards and Honors🏆

Dr. Sandrina Alves Heleno has received numerous awards and honors throughout her career. She was awarded an FCT postdoctoral grant from 2015 to 2018 and later secured a Junior Research Contract through the prestigious Scientific Employment Stimulus initiative in 2018. Dr. Heleno’s research achievements have been recognized with several national and international accolades, including three National Prizes—two BornFromKnowledge awards and the CA Crédito Agrícola prize—totaling €10,000. In 2019, her research team won the first place in the European Social Innovation prize, a distinction that came with a €50,000 award. One of her patents, which focuses on the development of natural preservatives, was transferred to industry and led to the creation of a spin-off company. Additionally, Dr. Heleno has been recognized by Stanford University as being among the top 2% most-cited researchers globally in the field of food science, highlighting her influence and impact in the academic and scientific community.

Conclusion

Sandrina Alves Heleno is a highly qualified and suitable candidate for the Industry Innovation Recognition Award. Her innovative contributions to food science and biotechnology, particularly in sustainable and green technologies, align with the goals of the award. Her proven ability to translate research into industry-relevant solutions, leadership in collaborative projects, and global recognition make her a strong contender. By further diversifying her industry partnerships and focusing on commercialization strategies, she could amplify the impact of her work, making her even more deserving of this recognition in the future.

Publications top noted📜
  • SA Heleno, A Martins, MJRP Queiroz, ICFR Ferreira
    Year: 2015
    Citation: 1034
    Title: Bioactivity of phenolic acids: Metabolites versus parent compounds: A review
    Journal: Food Chemistry, 173, 501-513
  • BR Albuquerque, SA Heleno, MBPP Oliveira, L Barros, ICFR Ferreira
    Year: 2021
    Citation: 525
    Title: Phenolic compounds: Current industrial applications, limitations and future challenges
    Journal: Food & Function, 12 (1), 14-29
  • N Halla, IP Fernandes, SA Heleno, P Costa, Z Boucherit-Otmani, et al.
    Year: 2018
    Citation: 401
    Title: Cosmetics preservation: a review on present strategies
    Journal: Molecules, 23 (7), 1571
  • ICFR Ferreira, SA Heleno, FS Reis, D Stojkovic, MJRP Queiroz, et al.
    Year: 2015
    Citation: 400
    Title: Chemical features of Ganoderma polysaccharides with antioxidant, antitumor and antimicrobial activities
    Journal: Phytochemistry, 114, 38-55
  • SA Heleno, L Barros, MJ Sousa, A Martins, ICFR Ferreira
    Year: 2010
    Citation: 369
    Title: Tocopherols composition of Portuguese wild mushrooms with antioxidant capacity
    Journal: Food Chemistry, 119 (4), 1443-1450
  • SA Heleno, ICFR Ferreira, AP Esteves, A Ćirić, J Glamočlija, A Martins, et al.
    Year: 2013
    Citation: 231
    Title: Antimicrobial and demelanizing activity of Ganoderma lucidum extract, p-hydroxybenzoic and cinnamic acids and their synthetic acetylated glucuronide methyl esters
    Journal: Food and Chemical Toxicology, 58, 95-100
  • SA Heleno, P Diz, MA Prieto, L Barros, A Rodrigues, MF Barreiro, et al.
    Year: 2016
    Citation: 202
    Title: Optimization of ultrasound-assisted extraction to obtain mycosterols from Agaricus bisporus L. by response surface methodology and comparison with conventional Soxhlet extraction
    Journal: Food Chemistry, 197, 1054-1063
  • SA Heleno, L Barros, A Martins, MJRP Queiroz, C Santos-Buelga, et al.
    Year: 2012
    Citation: 202
    Title: Fruiting body, spores and in vitro produced mycelium of Ganoderma lucidum from Northeast Portugal: A comparative study of the antioxidant potential of phenolic and …
    Journal: Food Research International, 46 (1), 135-140
  • L Barros, SA Heleno, AM Carvalho, ICFR Ferreira
    Year: 2010
    Citation: 190
    Title: Lamiaceae often used in Portuguese folk medicine as a source of powerful antioxidants: Vitamins and phenolics
    Journal: LWT – Food Science and Technology, 43 (3), 544-550
  • SA Heleno, L Barros, MJ Sousa, A Martins, ICFR Ferreira
    Year: 2009
    Citation: 182
    Title: Study and characterization of selected nutrients in wild mushrooms from Portugal by gas chromatography and high performance liquid chromatography
    Journal: Microchemical Journal, 93 (2), 195-199
  • O Taofiq, RC Calhelha, S Heleno, L Barros, A Martins, C Santos-Buelga, et al.
    Year: 2015
    Citation: 181
    Title: The contribution of phenolic acids to the anti-inflammatory activity of mushrooms: Screening in phenolic extracts, individual parent molecules and synthesized glucuronated and …
    Journal: Food Research International, 76, 821-827
  • JA Vaz, SA Heleno, A Martins, GM Almeida, MH Vasconcelos, et al.
    Year: 2010
    Citation: 165
    Title: Wild mushrooms Clitocybe alexandri and Lepista inversa: in vitro antioxidant activity and growth inhibition of human tumour cell lines
    Journal: Food and Chemical Toxicology, 48 (10), 2881-2884
  • O Taofiq, SA Heleno, RC Calhelha, MJ Alves, L Barros, et al.
    Year: 2017
    Citation: 159
    Title: The potential of Ganoderma lucidum extracts as bioactive ingredients in topical formulations, beyond its nutritional benefits
    Journal: Food and Chemical Toxicology, 108, 139-147
  • SA Heleno, D Stojković, L Barros, J Glamočlija, M Soković, A Martins, et al.
    Year: 2013
    Citation: 158
    Title: A comparative study of chemical composition, antioxidant and antimicrobial properties of Morchella esculenta (L.) Pers. from Portugal and Serbia
    Journal: Food Research International, 51 (1), 236-243
  • L Barros, SA Heleno, AM Carvalho, ICFR Ferreira
    Year: 2009
    Citation: 158
    Title: Systematic evaluation of the antioxidant potential of different parts of Foeniculum vulgare Mill. from Portugal
    Journal: Food and Chemical Toxicology, 47 (10), 2458-2464